Displaying 201–221 of 221 results for Paul Thomas, Managing Editor

Sort By Relevance Sort By Date
1... 5 6 7 8 9

Therapeutic Dose: The Scruffy Guy Cometh

(Article)

Director Michael Moore is pointing his lens toward the pharmaceutical industry, and drug company employees are on high alert. Love Moore or hate him, enjoy the limelight while it lasts, says Managing Editor Paul Thomas. Besides, an encounter might also be an opportunity to talk about the positive...

Therapeutic Dose: Canada and the Blame Game

(Article)

The drug importation issue: Stopping prescription drug shipments to online Canadian pharmacies only diverts attention from key safety and affordability issues, and a clear solution: track and trace technologies.

Isotope Analysis Expands Its Forensic Niche

(Article)

Remember isotopes from Chemistry 101? As used in Stable Isotope Analysis, they offer a surefire way to authenticate APIs and products without additives. John P. Jasper, who helped pioneer the technology, discusses what it can do and where it's heading.

Innovate Towards Known Drug Targets

(Article)

Of the top 10 best-selling drugs in 2003, just one was a first-in-class product — J&J’s Procrit. The other nine were latecomers, designed specifically to be best-in-class, that were able to overtake the early market entrant.

From the Editor: Striking a Balance

(Article)

The growth of generic drug manufacturing operations has challenged the pharmaceutical industry, legally, technologically and ethically. Generics manufacturers have injected some healthy competition into the industry, but they also have drug inventors scrambling to protect their hard-won ...

FDA's Pharmaceutical Inspectorate Searches for Higher Ground

(Article)

FDA wants its drug investigators to go to a higher level. Can they get there? Will they really make a difference?

Therapeutic Dose: The Relief Tsunami

(Article)

The humanitarian aid following December’s tsunami in south and southeast Asia has been unprecedented, and inspirational. Big players in the pharmaceutical industry have stepped up, with cash and supplies. Here are some initial, unofficial commitments.

Therapeutic Dose: For Business Ethics, Baxter Tries the Ripple Effect

(Article)

Stewardship concerns led Baxter Healthcare to create EthicsKit, an online guide to building an ethics program from scratch. Integrity led the company to share it.

Going Small, Thinking Big

(Article)

Multimedia Library

pharmaceutical manufacturing multimedia presentations

Sort By Relevance Sort By Date
1... 5 6 7 8 9